Advanced Filters
noise

hemophilia Clinical Trials

A listing of hemophilia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 99 clinical trials

Conditioned Pain Modulation in Patients With Hemophilia

Introduction: Hemophilic arthropathy is characterized by functional alterations, disabling physical sequelae, and chronic pain. Conditioned pain modulation describes the net effect of endogenous pathways that enhance or diminish the effects of afferent noxious stimuli. Objectives: To describe conditioned pain modulation in patients with hemophilia and identify the best predictive model …

20 - 65 years of age Male Phase N/A
J Jing Sun, Doctor

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

This study will assess the efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor

12 - 70 years of age All Phase 3
C Carmen Escuriola-Ettingshausen, MD

A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI

This research program is initiated to evaluate and document data on the success of ITI in 300 haemophilia A patients with newly developed or already existing FVIII-inhibitors (also patients who might potentially have failed in earlier ITIs), which will be treated with ITI - preferably high-dose based on individualized product …

years of age Male Phase N/A
L Laurent SATTLER, PharmD

Long-term Anticoagulation in a Patient With Severe Hemophilia A

To date, and to our knowledge, no case of severe hemophilia A patients receiving long-term anticoagulation has been published. Severe hemophilia A is a hereditary bleeding disorder characterized by a factor VIII (FVIII) deficiency of \<1%. Anticoagulation remains a real challenge in these patients, given the precarious hemostatic balance between …

18 years of age All Phase N/A

Effects of Photobiomodulation in Hemophilia Patients.

Hemophilia is a genetic bleeding disorder that commonly leads to knee hemarthrosis, causing pain, swelling, and reduced joint mobility in children. While standard treatments include clotting factor replacement and physiotherapy, additional non-invasive approaches are being explored. This study aims to evaluate the effects of photobiomodulation on knee hemarthrosis in male …

9 - 14 years of age All Phase N/A

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

This study will assess the safety and tolerability of SPK-8011QQ in adult males with moderately severe to severe hemophilia A.

18 years of age Male Phase 1/2
A Ayse Merve Tat, Assistant Professor

Joint Health, Balance and Quality of Life in Adults With Hemophilia A

Hemophilia is a hereditary bleeding disorder characterized by recurrent bleeding episodes, particularly into joints and muscles, leading to chronic musculoskeletal complications. Repeated joint bleeding may result in hemophilic arthropathy, which is associated with progressive joint damage, chronic pain, reduced mobility, and functional limitations. Advances in prophylactic treatment have significantly improved …

18 - 65 years of age Male Phase N/A
L Lung-Ji Chang, Ph.D

Lentiviral FVIII Gene Therapy

This study is a Phase I trial using an advanced lentiviral vector to deliver a functional gene for human clotting factor VIII into patients with hemophilia A, to evaluate the safety and efficacy of infusion of lentiviral gene modified autologous stem cells in patients.

2 - 65 years of age All Phase 1

A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People

The purpose of this study is to test a new medicine called Inno8. The study will test how eating and drinking before and after taking Inno8 affects how well it is absorbed in the stomach. The study consists of four arms. Participants will take the study medicine after an overnight …

18 - 45 years of age Male Phase 1

Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry

Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a molecular subtype with high malignancy and easy recurrence and metastasis. The emergence of HER2 targeted drugs has greatly improved the prognosis and survival of such patients. At present, for HER2 positive breast cancer patients with negative lymph nodes, …

12 years of age All Phase N/A

Simplify language using AI